Franklin
Lakes, NJ -- Thursday, January 06, 2000 -- BD (Becton,
Dickinson and Company) (NYSE: BDX) today applauded NJ Governor
Christie Todd Whitman for signing a bill that will require hospitals
to use needle-based medical devices designed to provide health care
workers with additional protection against accidental needlestick
injuries and potential exposure to infectious diseases such as
HIV/AIDS and hepatitis.
We applaud Governor Whitman for signing into law a bill designed
to protect the health and well-being of caregivers in our home
state, and we particularly commend New Jersey Assemblyman Alan
Augustine for his leadership in bringing this bipartisan bill to the
floor, said Kevin Seifert, VP-GM, BD Advanced Protection
Technologies. Assemblyman Augustine took into consideration the
concerns of all parties. The result is a bill that will allow for
the introduction of ever-improving new medical technologies, will
not single out any one companys products and, most importantly,
will not interfere with the delivery of superior patient care.
The legislation gives the New Jersey Health Department six months
to designate needles with safety devices. Each of New Jersey's 1,300
licensed health care facilities will be able to select needles from
a state-approved list, and hospitals, doctors' offices, and labs
will be required to provide training. The New Jersey law echoes
legislation requiring the use of safety-engineered devices passed in
California, Maryland, Tennessee, and Texas. At least another 20
states have similar legislation pending.
State legislative action on needle safety was matched in the
closing days of 1999 with significant movement by two federal
agencies. First, the Occupational Safety and Health Administration
(OSHA) issued a compliance directive to guide OSHA inspectors in
enforcing the standard that covers occupational exposure to
blood-borne pathogens and ensuring consistent inspection procedures.
In addition, a joint alert was issued by the National Institute of
Occupational Safety (NIOSH) and the Centers For Disease Control and
Prevention (CDC) to provide hospitals and employees with guidance on
how to establish a comprehensive program to reduce needlestick
injuries.
Becton Dickinson is a medical technology company that
manufactures and sells a broad range of supplies, devices and
systems for use by health care professionals, medical research
institutions, industry and the general public. For the fiscal year
ended September 30, 1999, Becton Dickinson reported total revenues
of $3.4 billion and net income of $276 million.